Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Cochin Shipyard among 10 smallcap stocks surge up to 57% this week
17/05/2025
Street Favourite ! SBI, Tata Motors among 10 large-cap stocks analysts expect to rally up to 32%
17/05/2025
For Trump, adulation and no risk of protests made the Gulf a dream trip
17/05/2025
Battered Wall Street short brigade is refusing to admit defeat
17/05/2025
Mind Over Money : From Mt. Everest Base Camp to boardroom - Shaji Varghese on fitness as a foundation for leadership
17/05/2025
North Korea's Kim Jong Un oversees air drills, calls for stepped-up war preparation
17/05/2025
